China SXT Pharmaceuticals, Inc.

DB:2RY0 Stock Report

Market Cap: €1.3m

China SXT Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2RY0?
Owner TypeNumber of SharesOwnership Percentage
Institutions46,8401.35%
Individual Insiders410,04211.8%
General Public3,019,20986.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 514.7%.

Top Shareholders

Top 10 shareholders own 13.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.7%
John Fife
405,837€152.0k0%no data
0.44%
Baader Bank AG, Asset Management Arm
15,161€5.7k0%no data
0.35%
GSA Capital Partners LLP
12,300€4.6k0%no data
0.29%
BMO Asset Management Corp.
10,000€3.7k0%no data
0.25%
UBS Asset Management AG
8,678€3.3k-31%no data
0.12%
Feng Zhou
4,205€1.6k0%no data
0.011%
Acadian Asset Management LLC
379€141.9-86.3%no data
0.011%
JPMorgan Chase & Co, Brokerage and Securities Investments
376€140.90%no data
0.0013%
Avanza Fonder AB
45€16.8-99.8%no data
0.00003%
BCV Asset Management
1€0.40%no data